The Premium Problem in Plain Terms
When the ACA marketplaces opened in 2014, supporters predicted competition among insurers would hold premiums in check. For the first few years, benchmark premiums were relatively stable in many states. But beginning around 2017, premiums in many markets spiked — in some states by double-digit percentages in a single year. While expanded subsidies under the American Rescue Plan temporarily shielded many enrollees from the full impact, the underlying cost pressures remain. Here's why.
1. Adverse Selection and the Risk Pool
Insurance works when the healthy and the sick are pooled together. Premiums from low-risk enrollees help pay claims from high-risk ones. The ACA's design was meant to enforce this pooling through the individual mandate — requiring healthy people to buy coverage or pay a penalty.
When Congress reduced the individual mandate penalty to zero in 2017 (effective 2019), the enforcement mechanism disappeared. Healthier individuals who found premiums unaffordable without subsidies could opt out entirely, leaving a sicker, more expensive pool behind. This adverse selection cycle — fewer healthy enrollees, higher claims, higher premiums, even fewer healthy enrollees — is a structurally predictable consequence of a mandate without teeth.
2. Insurer Exits and Reduced Competition
In the early years of the marketplaces, several large national insurers — including UnitedHealth, Aetna, and Humana — withdrew from most ACA markets after reporting significant losses. In some rural counties, this left enrollees with only one insurer option. When competition evaporates, so does the price discipline it creates.
Carrier participation has recovered in some markets, but geographic concentration remains a problem. A marketplace with one insurer is not a functioning market in any meaningful economic sense.
3. Underlying Healthcare Cost Inflation
Health insurance premiums are ultimately a function of healthcare costs. The ACA did relatively little to address the underlying prices charged by hospitals, specialists, pharmaceutical manufacturers, and medical device companies. Hospital consolidation — which accelerated after 2010 — has reduced competition among providers and given health systems greater pricing power over insurers.
When the cost of actually delivering care rises faster than general inflation, premiums must follow. This dynamic exists independent of the ACA's specific rules, but the law did not create effective mechanisms to counteract it.
4. The Benefit Mandate Floor
As discussed elsewhere, the ACA's Essential Health Benefits requirements set a minimum for what plans must cover. While these protections benefit many enrollees, they also establish a cost floor below which premiums cannot realistically fall. Plans cannot offer stripped-down, lower-cost options that might attract younger, healthier enrollees — limiting the risk pool expansion that would otherwise moderate premiums.
5. The Subsidy Structure and Its Limits
The ACA's premium tax credits shield many lower-income enrollees from the full cost of marketplace plans. But the credits are tied to the cost of a benchmark plan, meaning that as premiums rise, federal subsidy costs rise too — without solving the underlying problem. For households above the subsidy thresholds (historically 400% of the federal poverty level), premium increases hit with full force, creating a significant gap in affordability for middle-income Americans who earn too much for subsidies but too little to absorb $500–$800 monthly premiums comfortably.
What Would Actually Bend the Cost Curve?
Economists across the ideological spectrum generally agree that meaningful premium reduction requires addressing healthcare costs themselves — not just rearranging who pays them. Proposals range from strengthening price transparency rules and allowing more cross-state insurance competition, to aggressive hospital antitrust enforcement, to reference pricing and global budgets. The ACA framework largely left these levers untouched.
| Cost Driver | ACA's Response | Effectiveness |
|---|---|---|
| Adverse selection | Individual mandate | Weakened by zero-dollar penalty |
| Insurer monopolies | State-run exchanges | Mixed; exits reduced competition |
| Provider price inflation | Minimal direct action | Limited |
| Benefit scope | EHB mandate | Raised cost floor |